Author: admin

Benefit-cost analysis is a well-established and widely used approach for systematically assessing policy impacts, as discussed by CHDS’s Lisa Robinson in a recent Free Range Podcast.

CHDS’ Allison Portnoy, Emily Burger, Jane Kim, and Stephen Sy and colleagues from the University of Oslo collaborated with The Section for Cervical Cancer Screening in Norway to design and analyze

CHDS affiliate Lisa Prosser received the Society for Medical Decision Making (SMDM) Award for Distinguished Service at the 45th North American meeting in Philadelphia in October, 2023. The award recognizes

CHDS affiliates were honored with the Best Paper Award from the journal Risk Analysis at the 2023 Society for Risk Analysis annual meeting. The paper, “The Benefits and Costs of U.S. Employer

Members of the CHDS community contributed to the 45th North American Society for Medical Decision Making (SMDM) Meeting, held in Philadelphia in October, 2023. The theme was “Innovation

CHDS faculty Eve Wittenberg co-chaired an international task force developing recommendations for the inclusion of caregiver and family member impacts in the economic evaluation of healthcare interventions;

The COVID-19 pandemic stimulated debate about the extent to which societies are willing to make trade-offs between health and economic activity. At a recent CHDS seminar, Emily Lancsar

The U.S. Office of Management and Budget (OMB) recently substantially revised its guidance on evaluating major regulations and government investments, which will have profound effects on how agencies estimate

CHDS faculty Thomas Gaziano, in collaboration with Harvard Chan researchers and colleagues in South Africa, received additional funding to continue and expand work in the HAALSA

CHDS faculty Davene Wright has been promoted to Associate Professor in the Department of Population Medicine (DPM) at Harvard Medical School and the Harvard Pilgrim Healthcare Institute,